C277
Chloro-IB-MECA
solid, ≥98% (HPLC)
别名:
2-Chloro-N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, Cl-IB-MECA
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C18H18ClIN6O4
化学文摘社编号:
分子量:
544.73
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
产品名称
Chloro-IB-MECA, solid, ≥98% (HPLC)
InChI key
IPSYPUKKXMNCNQ-PFHKOEEOSA-N
SMILES string
CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc23
InChI
1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1
assay
≥98% (HPLC)
form
solid
color
white
solubility
DMSO: >20 mg/mL
Quality Level
Gene Information
human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140)
rat ... Adora1(29290), Adora2a(25369), Adora3(25370)
Biochem/physiol Actions
2-chloro-N(6)-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide (Cl-IB-MECA) is a adenosine receptor. It protects against myocardial ischemia/reperfusion injury in mice.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
K Stambaugh et al.
The American journal of physiology, 273(1 Pt 2), H501-H505 (1997-07-01)
The possible cardioprotective roles of adenosine A1 and A3 receptors were investigated in a cardiac myocyte model of injury. The adenosine A3 receptor is a novel cardiac receptor capable of mediating potentially important cardioprotective functions. Prolonged hypoxia with glucose deprivation
The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices
Laudadio MA, et al.
Epilepsy Research, 59(2), 83-94 (2004)
Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl) adenosine-5?-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine Receptor
Ge ZD, et al.
Journal of Pharmacology and Experimental Therapeutics, 319(3), 1200-1210 (2006)
Y Yao et al.
Biochemical and biophysical research communications, 232(2), 317-322 (1997-03-17)
The effects of novel, selective adenosine (ADO) A3 receptor antagonists of diverse structure on cells of the human HL-60 leukemia and U-937 lymphoma cell lines were examined. Both 3-ethyl 5-benzyl 2-methyl-6-phenyl-4-phenylethynyl-1,4-(+/-)-dihydropyridine-3, 5-dicarboxylate (MRS 1191, 0.5 microM) and 6-carboxy-methyl-5, 9-dihydro-9-methyl-2-phenyl-[1,2,4]-triazolo [5,1-a][2,7]naphthyridine
Melanie Wurm et al.
Molecular cancer therapeutics, 20(11), 2250-2261 (2021-09-06)
Despite some impressive clinical results with immune checkpoint inhibitors, the majority of patients with cancer do not respond to these agents, in part due to immunosuppressive mechanisms in the tumor microenvironment. High levels of adenosine in tumors can suppress immune
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持